Evidence map›Paper›PMID 40593808›Full record

ArticleNPJ vaccines2025

Age-associated defect in ADCC response to COVID-19 vaccine.

Benjamin L Sievers, Mazharul Altaf, Mark T K Cheng, Kimia Kamelian, Claire Cormie, CITIID-NIHR BioResource COVID-19 Collaboration, Rainer Doffinger, Ravindra K Gupta

Abstract read
In one paragraph

Article in NPJ vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Benjamin L SieversDepartment of Medicine, University of Cambridge, Cambridge, UK.
Mazharul AltafDepartment of Medicine, University of Cambridge, Cambridge, UK.
Mark T K ChengDepartment of Medicine, University of Cambridge, Cambridge, UK.
Kimia KamelianDepartment of Medicine, University of Cambridge, Cambridge, UK.
Claire CormieDepartment of Medicine, University of Cambridge, Cambridge, UK.
CITIID-NIHR BioResource COVID-19 Collaboration
Rainer DoffingerCambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, Cambridgeshire, United Kingdom.
Ravindra K GuptaDepartment of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.

Funding

Wellcome TrustWellcome Trust WT108082AIA
6 · The paper itself

Abstract

We investigated age-associated effects of SARS-CoV-2 vaccination in elderly individuals (n = 50, mean age 79) after six SARS-CoV-2 vaccine doses. While neutralization titers remained comparable across age groups, Fc-mediated effector functions declined with age. Individuals >80 demonstrated reduced antibody-dependent cellular cytotoxicity (ADCC), via a surrogate ADCC-signaling assay, correlating with diminished IgG1 binding. These findings highlight age-related impairments in Fc-mediated responses, with implications for immune protection and vaccine strategies in older populations.

Identifiers

PMID40593808
PMCPMC12217920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.